Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome resulting from excessive secretion of fibroblast growth factor-23 (FGF23) by phosphaturic mesenchymal tumors (PMTs). This evidence concerns the gene FGF23 and phosphaturic mesenchymal tumor.